Proliferation potential of spinal meningiomas

Abramovich CM, Prayson RA (1998) MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol 29:1420–1427

Abramovich CM, Prayson RA (1999) Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 123:793–800

Bitzer M, Opitz H, Popp J, Morgalla M, Gruber A, Heiss E, Voigt K (1998) Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien) 140:333–340

Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H (1993) Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33:212–217

Crompton MR, Gautier-Smith PC (1970) The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiatry 33:80–87

Fewings PE, Battersby RD, Timperley WR (2000) Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence?. J Neurosurg 92:401–405

Gezen F, Kahraman S, Canakci Z, Beduk A (2000) Review of 36 cases of spinal cord meningioma. Spine 25:727–731

Hossmann KA, Zulch KJ (1966) The spinal psammomatous meningiomas of women. Neurochirurgia (Stuttg) 9:106–113

Hsu DW, Efird JT, Hedley-Whyte ET (1998) MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF α) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol Appl Neurobiol 24:441–452

Izycka-Swieszewska E, Rzepko R, Borowska-Lehman J, Baranowska E, Warzocha D (1999) Recurrent meningiomas–the immunohistochemical analysis of angiogenesis and cellular proliferation. Preliminary study Folia Neuropathol 37:179–184

Jallo GI, Kothbauer KF, Silvera VM, Epstein FJ (2001) Intraspinal clear cell meningioma: diagnosis and management: report of two cases. Neurosurgery 48:218–221

Jellinger K, Slowik F (1975) Histological subtypes and prognostic problems in meningiomas. J Neurol 208:279–298

Karamitopoulou E, Perentes E, Tolnay M, Probst A (1998) Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29:140–145

Kleihues P, Burger PC, Scheithauer B (1993) The new WHO classification of brain tumors. Brain Pathol 3:255–268

Klekamp J, Samii M (1996) Surgical results of spinal meningiomas. Acta Neurochir Suppl (Wien) 65:77–81

Klekamp J, Samii M (1999) Surgical results for spinal meningiomas. Surg Neurol 52:552–562

Langford LA, Cooksley CS, DeMonte F (1996) Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. Hum Pathol 27:350–354

Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol (Berl) 91:504–510

Matsuno A, Nagashima T, Matsuura R, Tanaka H, Hirakawa M, Murakami M, Tamura A, Kirino T (1996) Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106:776–781

Meinsma-vdTuin M, Molenaar WM, Mooij JJ (2000) Spinal papillary meningioma: a case report and review of the literature. Acta Neurochir (Wien) 142:703–708

Moller ML, Braendstrup O (1997) No prediction of recurrence of meningiomas by PCNA and Ki-67 immunohistochemistry. J Neurooncol 34:241–246

Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249–2254

Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M (2001) Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 25:472–478

Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M (1994) MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer 74:3176–3189

Perry A, Chicoine MR, Filiput E, Miller JP, Cross DT (2001) Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients. Cancer 92:701–711

Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262–2269

Philippon J, Cornu P, Grob R, Rivierez M (1986) Les mèningiomes récidivantes. Neurochirurgie 32:54–62

Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140

Roser F, Nakamura M, Bellinzona M, Rosahl SK, Ostertag H, Samii M (2004) The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 57:1033–1037

Roser F, Samii M, Ostertag H, Bellinzona M (2004) The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37–44

Roux FX, Nataf F, Pinaudeau M, Borne G, Devaux B, Meder JF (1996) Intraspinal meningiomas: review of 54 cases with discussion of poor prognosis factors and modern therapeutic management. Surg Neurol 46:458–463

Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39

Solero CL, Fornari M, Giombini S, Lasio G, Oliveri G, Cimino C, Pluchino F (1989) Spinal meningiomas: review of 174 operated cases. Neurosurgery 25:153–160

Stechison MT, Tasker RR, Wortzman G (1987) Spinal meningioma en plaque Report of two cases. J Neurosurg 67:452–455